Companies / Brazil
Sanofi-Aventis Regains Brazil Sales Lead
April 2006 | Company Finance AlertFrench drug major Sanofi-Aventis has regained its leading sales position on Brazil's pharmaceutical market, according to IMS Health. In the first quarter of 2006, the company has a market share of 6.43%, with leading products Novalgin (dipyrone) and Dorflex (dipyrone+orphenadrine+caffeine) remaining among the market's best sellers. The company was closely followed by former market leader Aché - recently enlarged by its acquisition of fellow Brazilian firm Biosintética - and another local producer, EMS-Sigma. Sanofi's 2005 sales totalled some BRL2bn (US$925mn), according to the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
